HUDSON, Wis.—Phillips-Medisize, a Molex company, recently broke ground on a new state-of-the-art manufacturing facility located in the St. Croix Meadows development in Hudson, Wisconsin. This site is expected to support at least 230,000 square feet of manufacturing space for FDA-regulated products, the company said in a press release.
“The St. Croix Meadows redevelopment is aimed at transforming the riverfront community,” said Hudson Mayor Rich O’Connor, in a prepared statement. “By creating employment opportunities with Phillips-Medisize, I hope to encourage young people to stay in Hudson.”
Other presenters at the groundbreaking included Klint Klaas, representative of the developer, who initiated and shaped the vision of the new St. Croix Meadows re-development project. Representing Phillips-Medisize, Dave Thoreson, vice president and general manager of North America Medical, graciously acknowledged the developer and the City of Hudson planning teams for their roles in advancing the project. The event culminated in the ceremonial turning of the soil, marking the official launch of construction. The Phillips-Medisize St. Croix Meadows facility is slated for completion in the late 2019 to mid-2020 timeframe, the company said.
“We are proud to invest in growing Phillips-Medisize’s manufacturing presence in our founding state of Wisconsin,” stated Matt Jennings, CEO and president, Phillips-Medisize. “Hudson has been home to Phillips-Medisize for the past 36 years, so we are excited to reinforce our commitment to the vibrant community with our St. Croix Meadows facility. We expect to support over 250 employment opportunities for area residents in jobs, ranging from skilled manufacturing to engineering. It also reaffirms our commitment to better serve customers as a global end-to-end provider of innovation, development, and manufacturing solutions.”
Founded in the town of Phillips, Wisconsin, over five decades ago, Phillips-Medisize currently employs more than 5,500 people at 26 manufacturing sites around the world. This new Phillips-Medisize facility will be situated on a 34-acre site in St. Croix Meadows development, representing the company’s single largest operation in Wisconsin, with opportunity to expand.
The Phillips-Medisize St. Croix Meadows manufacturing facility will be FDA-registered, adhering to clean room practices, and featuring state-of-the-art equipment to meet quality production standards.
Phillips-Medisize, a Molex (www.molex.com) company, provides development and manufacturing services to the pharmaceutical, diagnostics, medical device, and specialty commercial market segments. The company said that its core advantage is “the knowledge of its people to integrate design, molding, electronics, and automation” to provide “innovative, high-quality manufacturing solutions.”